Genomic analysis in short- and long-term patients with malignant pleura mesothelioma treated with palliative chemotherapy

Malignant pleural mesothelioma (MPM) is an aggressive tumour with poor prognosis. The aim of this study was to identify genetic mutations associated with poor or extended survival in patients who received palliative chemotherapy.

Source: European Journal of Cancer - April 23, 2020 Category: Cancer & Oncology Authors: Federica Torricelli, Alka Saxena, Rosamond Nuamah, Michael Neat, Leanne Harling, Wen NG, James Spicer, Alessia Ciarrocchi, Andrea Bille Tags: Original Research Source Type: research